Advertisement

Topics

TARIS Biomedical LLC and Uppsala Clinical Research Center Company Profile

21:08 EDT 23rd April 2018 | BioPortfolio

UCR’s mission is to improve human health in Sweden and worldwide. UCR has the competence and technology necessary to transform innovative ideas into translational research projects, clinical studies, and registry-based improvement projects. UCR is organized as an independent, non-profit research center affiliated with Uppsala University and Uppsala University Hospital.www.ucr.uu.se


News Articles [2651 Associated News Articles listed on BioPortfolio]

TARIS, BMS Announce Clinical Trial Collaboration

NewsBladder cancer affects more than 2.7 million patients worldwide, and is among one of the most expensive types of cancers to treat on a per-patient lifetime basis.

Yonghua Capital Leads $25 Million B Round in Taris Biomedical

Shanghai's Yonghua Capital, a private equity investor with an interest in life science, led a $25 million Series B funding in Taris Biomedical. Taris is a Boston-area company that is developing implan...

TARIS® Announces Research Collaboration Focused on Natural History of Muscle Invasive Bladder Cancer Patients Not Receiving Curative Intent Therapy

Collaboration with Uppsala Clinical Research Center and Professor Per-Uno Malmström TARIS Biomedical LLC announced today that it has engaged in a research colla...

TARIS to begin Phase lb trial of TAR-200 and Opdivo combination

TARIS Biomedical has partnered with Bristol-Myers Squibb to undertake a Phase lb clinical trial of TAR-200 (GemRIS) in combination with...Read More... The post TARIS to begin Phase lb trial of TAR-200...

TARIS ® to Present at Cowen Health Care Conference

TARIS announced that CEO Purnanand Sarma is presenting today, March 12th, at the Cowen and Company 38th Annual Health Care Conference from 8:30-8:55 a.m. ET in the Northeas...

Taris and BMS team up for Phase I trial in bladder cancer

Taris Biomedical LLC agreed to conduct a combination clinical trial of its TAR200 (GemRIS) with Bristol-Myers Squibb Co.'s Opdivo (nivolumab) in muscle-invasive bladder cancer patients who are schedul...

Bristol-Myers makes equity investment in Taris Biomedical

Bristol-Myers Squibb has made an equity investment in Taris Biomedical, a therapeutically urology company engaged in the development of treatments for patients suffering from difficult-to-treat bladde...

TARIS Biomedical Announces $25M Series B Financing

TARIS Biomedical LLC , a company developing targeted new therapies for millions of patients suffering from difficult-to-treat bladder diseases, announced today that it has raised $25M in a Series B fi...

PubMed Articles [5918 Associated PubMed Articles listed on BioPortfolio]

Clinical Research Nursing: Development of a Residency Program
.

Clinical research nurses are essential in the coordination of clinical trials and the management of research participants. Without a stable, knowledgeable research nurse workforce, the conduct of rese...

Regenerative Medicine Strategies in Biomedical Implants.

Recently, significant progress has been made in the research related to regenerative medicine. At the same time, biomedical implants in orthopedics and dentistry are facing many challenges and posing ...

Responsible Conduct of Human Subjects Research in Islamic Communities.

In order to increase understanding of the ethical implications of biomedical, behavioral and clinical research, the Fogarty International Center, part of the United States National Institutes of Healt...

Assessing the Practice of Biomedical Ontology Evaluation: Gaps and Opportunities.

With the proliferation of heterogeneous health care data in the last three decades, biomedical ontologies and controlled biomedical terminologies play a more and more important role in knowledge repre...

Blood donors' preferences for blood donation for biomedical research.

Increasing numbers of blood donors are recruited to participate in biomedical research. As blood services depend on voluntary donors, successful recruitment calls for a better understanding of donors'...

Clinical Trials [5172 Associated Clinical Trials listed on BioPortfolio]

Safety and Tolerability Study of the Taris Placebo System

The aim of this protocol is to evaluate the tolerability of the Taris placebo system for the development program and to provide key safety and tolerability data for the Taris platform.

Bigfoot Biomedical Clinical Research Center (CRC) Trial

The trial is designed to assess safety and feasibility of the Bigfoot Biomedical Type 1 Diabetes Management System (T1DMS) in up to 50 participants in a closely monitored Clinical Research...

How Participants Perceive Biomedical Research in Pulmonology

The primary objective of this study is to determine how biomedical research is perceived by patients already participating in a pulmonology research project.

A Pilot Scheme - Specimen Collection of Health Management Center

Biomedical and biotechnology industry is internationally regarded as the most brilliant star performer of the future. The development of biomedical depends on a high quality academic resea...

Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center

More than 10 million Americans have chronic kidney disease and every year, approximately 100,000 new patients develop end stage renal disease (ESRD) resulting in incalculable human sufferi...

Companies [5150 Associated Companies listed on BioPortfolio]

TARIS Biomedical LLC and Uppsala Clinical Research Center

UCR’s mission is to improve human health in Sweden and worldwide. UCR has the competence and technology necessary to transform innovative ideas into translational research pr...

TARIS Biomedical LLC

TARIS Biomedical® is building a unique therapeutically-focused urology company, developing targeted new treatments for millions of patients suffering from difficult-to-treat ...

Bristol-Myers Squibb and TARIS Biomedical LLC

TARIS Biomedical® is building a unique therapeutically-focused urology company, developing targeted new therapies for millions of patients suffering from difficult-to-treat ...

TARIS Biomedical

TARIS Biomedical Inc., a specialty pharmaceutical company with deep domain expertise in therapeutics and drug-delivery, is focused on local minimally-invasive drug-device converge...

Uppsala Science Park KB

Uppsala Science Park is located in the centre of the campus that contains Uppsala's two universities, which together consist of 200 research and educational departments. There are about 150 companie...

More Information about "TARIS Biomedical LLC and Uppsala Clinical Research Center" on BioPortfolio

We have published hundreds of TARIS Biomedical LLC and Uppsala Clinical Research Center news stories on BioPortfolio along with dozens of TARIS Biomedical LLC and Uppsala Clinical Research Center Clinical Trials and PubMed Articles about TARIS Biomedical LLC and Uppsala Clinical Research Center for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of TARIS Biomedical LLC and Uppsala Clinical Research Center Companies in our database. You can also find out about relevant TARIS Biomedical LLC and Uppsala Clinical Research Center Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record